Journal of Ocular Pharmacology and Therapeutics

Journal of Ocular Pharmacology and Therapeutics The official journal of the Association for Ocular Pharmacology and Therapeutics Published by Mary Ann Liebert Inc. www.liebertpub.com/jop The only multidisciplinary peer-reviewed journal that covers basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose, ocular diseases and disorders.
Audience	Researchers and clinicians, including all members of the Association for Ocular Pharmacology and Therapeutics
Frequency	6 issues a year: February, April, June, August, October, December
Editorial Focus	Publishes manuscripts related to the pharmacokinetics and pharmacodynamics of biopharmaceuticals related to the treatment of the eye. Topics covered include: Glaucoma Cataracts Retinal degeneration Proliferative disorders of the eye Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Gene therapy Ocular metabolic disorders Ocular ischemia and blood flow Ocular inflammatory and immune disorders
Editor(s) in Chief	Craig E. Crosson, Ph.D. Medical University of South Carolina, Charleston Associate Editor David E. Potter, Ph.D. Medical University of South Carolina, Charleston
Print Advertising Options	Adverts, Inserts & Supplements
Digital Advertising Options	Banners on website Banners on subscriber Table of Contents email alerts
Further Information	Heleen Vodégel Tel: +44 (0) 1875 825 700 hvodegel@impressmedia.com
Publisher	Journal of Ocular Pharmacology and Therapeutics is owned and published by Mary Ann Liebert, Inc. Editorial headquarters: 140 Huguenot Street, New Rochelle, New York 10801, USA. Phone: +1 (914) 740-2100. Fax: +1 (914) 740-2101 www.liebertpub.com